For this observational study, we enrolled a total of 89 patients with open-angle glaucoma (OAG) who had shown clinically confirmed structural progression during their respective follow-up periods at the Department of Ophthalmology of Seoul National University Hospital from October 2012 to December 2017. The patients were participants in the Macular Ganglion Cell Imaging Study, which was a prospective study designed in 2011 and is ongoing. From 282 patients in the cohort, 89 patients (31.6%) were enrolled in this study. All the patients underwent a complete ophthalmologic examination, including visual acuity testing, manifest refraction assessment, slit-lamp examination, intraocular pressure measurements using Goldmann applanation tonometry, gonioscopy, dilated fundus examination, axial length measurement (Axis II PR; Quantel Medical, Inc., Bozeman, MT), stereo-disc photography and red-free RNFL photography (TRC-50IX; Topcon Corporation, Tokyo, Japan), Swedish interactive thresholding algorithm 30-2 perimetry (Humphrey Field Analyzer II; Carl Zeiss Meditec, Jena, Germany), and Cirrus HD-OCT (Carl Zeiss Meditec, Inc., Dublin, CA). Both the eyes were imaged with Cirrus HD-OCT and examined with standard automated perimetry every 6 to 12 months for at least 36 months.
Patients with OAG were identified by the presence of a characteristic optic disc (i.e., localized or diffuse neuroretinal rim thinning, increased cupping or cup-to-disc ratio difference of >0.2 between the eyes) on stereo-disc photography, the presence of RNFL defect on red-free fundus imaging regardless of the presence or absence of glaucomatous visual field defects, and an open angle confirmed on gonioscopy.
Progressive optic disc changes (i.e., focal or diffuse rim narrowing, neuroretinal rim notching, increased cup-to-disc ratio, and adjacent vasculature position shift) were determined by comparison of serial stereo-disc photographic images and regarded as indicative of glaucoma progression. Changes in RNFL defects were determined from serial red-free RNFL photographs and defined as the appearance of a new defect or an increase in the width or depth of an existing defect. These changes were regarded as indicative of clinically confirmed structural progression.
21 Two observers (W.J.L., M.S.), who were masked to all other patient information, independently evaluated all the photographs. In cases of a disagreement, a third glaucoma specialist (K.H.P.) served as an adjudicator.
The inclusion criteria were as follows: (1) unilateral or bilateral OAG, (2) clinically confirmed structural progression in the follow-up period, and (3) follow-up examination for more than 36 months with at least four serial RNFL and GCIPL OCT measurements as well as standard automated perimetry. Additionally, patients eligible for inclusion in the study had to have a best-corrected visual acuity of 20/40 or better, spherical equivalent refractive errors from +6.0 to −6.0 diopters, and cylinder correction of less than 3.0 diopters. The exclusion criteria were as follows: a history of ophthalmic surgery (e.g., glaucoma-filtering surgery), any other ocular disease that could interfere with the visual function, any media opacity that would significantly interfere with acquisition of OCT images, inability to obtain a high-quality OCT image (i.e., signal strength of <6), and severe glaucoma showing a mean deviation worse than –20 dB.
22 We excluded severe glaucoma patients for two reasons. First, in the severe stage, there are many diffuse damages on the deviation map. Second, the progression pattern is not well-detected on the GPA owing to the floor effect, especially in the peripapillary RNFL. For cases in which both the eyes met all the eligibility criteria, one eye was randomly chosen as the study eye.